Yahoo Finance

Why Penumbra (PEN) Shares Are Falling Today

Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results from its landmark STORM-PE randomized controlled trial. The study found that ...
Yahoo Finance

Why Penumbra (PEN) Stock Is Up Today

Shares of medical device company Penumbra (NYSE:PEN) jumped 17.2% in the morning session after it reported third-quarter 2025 financial results that surpassed Wall Street's expectations for both ...
Yahoo Finance

Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for ...

ALAMEDA, Calif., Oct. 27, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical ...
NBC4 Columbus

Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary ...

ALAMEDA, Calif., Nov. 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), which found that the use of ...
The Globe and Mail

Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Penumbra Inc. is ...